FMJ Debruyne

p53 mutations have no additional prognostic value over stage in bladder cancer

P P Bringuier, HFM Karthaus, FMJ Debruyne et al. · British Journal of Cancer · 1994 · 53 citations · Full text

Urology, P53 Mutations, Additional Prognostic Value +8

p16 mutations/deletions are not frequent events in prostate cancer

Yahya Tamimi, P P Bringuier, Frank Smit et al. · British Journal of Cancer · 1996 · 47 citations · Full text

Urology, Medicine, Pathology +3

High energy transurethral thermotherapy in the treatment of benign prostatic hyperplasia: criteria to predict treatment outcome

FCH d’Ancona, E.A.E. Francisca, JCM Hendriks et al. · Prostate Cancer and Prostatic Diseases · 1999 · 22 citations

Treatment Outcome, Urology, Benign Prostatic Hyperplasia +4

Transrectal ultrasound imaging of the prostate: review and perspectives of recent developments

J.P. Michiel Sedelaar, JJMCH de la Rosette, HP Beerlage et al. · Prostate Cancer and Prostatic Diseases · 1999 · 13 citations

Medical Ultrasound, Urology, Focused Ultrasound +9